Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease
- PMID: 9476721
- DOI: 10.1159/000007894
Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease
Abstract
Dystonia is a common manifestation in Wilson's disease (WD). The striatum, especially the putamen, has been considered to be responsible for dystonia. We reported 3 patients who developed acute generalized dystonia and akinetic rigid syndrome following an initial therapy with d-penicillamine 125-500 mg daily. Brain MRI revealed lesions in the thalamus and the brainstem, particularly the tegmentum, and the basis pontis in addition to the basal ganglion lesions. After the episode, 1 patient continued to receive d-penicillamine therapy and 2 changed to zinc sulfate treatment. The generalized dystonia improved in the following 3 months and 3 years respectively in 2 patients. Follow-up brain MRI of these 2 patients revealed that the lesions in the thalamus and brainstem disappeared or resolved almost completely. From these data, acute generalized dystonia with brainstem and thalamic lesions may occur in WD patients after an initial d-penicillamine therapy. Furthermore, the dystonia may resolve following the disappearance of the brainstem and thalamic lesions.
Similar articles
-
Wilson's disease: resolution of MRI lesions following long-term oral zinc therapy.Acta Neurol Scand. 1996 Feb-Mar;93(2-3):215-8. doi: 10.1111/j.1600-0404.1996.tb00203.x. Acta Neurol Scand. 1996. PMID: 8741147
-
Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.Mov Disord. 2001 May;16(3):568-9. doi: 10.1002/mds.1111. Mov Disord. 2001. PMID: 11391761
-
[A study of trientine therapy in Wilson's disease with neurological symptoms].No To Hattatsu. 1993 Sep;25(5):429-34. No To Hattatsu. 1993. PMID: 8398232 Japanese.
-
Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson's disease: report of a case.J Formos Med Assoc. 1992 Jun;91(6):627-9. J Formos Med Assoc. 1992. PMID: 1358351
-
Resolution of cranial MRI and SPECT abnormalities in a patient with Wilson's disease following oral zinc monotherapy.Intern Med. 2012;51(13):1759-63. doi: 10.2169/internalmedicine.51.7341. Epub 2012 Jul 1. Intern Med. 2012. PMID: 22790141
Cited by
-
Microstructure changes in whiter matter relate to cognitive impairment in Wilson's disease.Biosci Rep. 2019 Mar 15;39(3):BSR20181651. doi: 10.1042/BSR20181651. Print 2019 Mar 29. Biosci Rep. 2019. PMID: 30804230 Free PMC article.
-
Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.Mol Cell Biochem. 2001 Dec;228(1-2):73-82. doi: 10.1023/a:1013348005312. Mol Cell Biochem. 2001. PMID: 11855743
-
Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.Neuroradiology. 2007 Jul;49(7):571-8. doi: 10.1007/s00234-007-0220-6. Epub 2007 Mar 3. Neuroradiology. 2007. PMID: 17334752
-
Management of Status Dystonicus Beyond Intensive Care: An Etiology-Specific Approach.Ann Indian Acad Neurol. 2023 May-Jun;26(3):213-214. doi: 10.4103/aian.aian_253_23. Epub 2023 May 18. Ann Indian Acad Neurol. 2023. PMID: 37538412 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical